Sanara MedTech (SMTI) Amortization of Deferred Charges (2023 - 2025)
Sanara MedTech's Amortization of Deferred Charges history spans 6 years, with the latest figure at $606197.0 for Q4 2025.
- For Q4 2025, Amortization of Deferred Charges rose 46.11% year-over-year to $606197.0; the TTM value through Dec 2025 reached $2.2 million, up 161.22%, while the annual FY2025 figure was $2.2 million, 162.18% up from the prior year.
- Amortization of Deferred Charges reached $606197.0 in Q4 2025 per SMTI's latest filing, up from $598172.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $606197.0 in Q4 2025 to a low of $2055.0 in Q3 2023.
- Average Amortization of Deferred Charges over 3 years is $304680.0, with a median of $336758.5 recorded in 2024.
- Peak YoY movement for Amortization of Deferred Charges: soared 13357.61% in 2024, then soared 46.11% in 2025.
- A 3-year view of Amortization of Deferred Charges shows it stood at $3083.0 in 2023, then skyrocketed by 13357.61% to $414898.0 in 2024, then skyrocketed by 46.11% to $606197.0 in 2025.
- Per Business Quant, the three most recent readings for SMTI's Amortization of Deferred Charges are $606197.0 (Q4 2025), $598172.0 (Q3 2025), and $583920.0 (Q2 2025).